FREDERICK FLORES: Open Payments
NPI 1053973529 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,362 in 65 payments from 17 companies in 2025. Trend: 2023 $1,874 · 2024 $1,886 · 2025 $1,362
Food & beverage: $1,362
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $484 |
| Lilly USA, LLC | 16 | $339 |
| GlaxoSmithKline, LLC. | 5 | $101 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| ABBVIE INC. | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| SANOFI PASTEUR INC. | 1 | $25 |
| CSL Behring | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: Ozempic, JARDIANCE, MOUNJARO, TRELEGY ELLIPTA, Rybelsus, Kerendia, Wegovy, FARXIGA.
Industry payments across TX — which companies pay providers there.
